Search research articles
Contact Us
Filters
Showing results (41-50 of 280) with videos related to
Page
of 28
Sort By:
COPD
|
September 22, 2010
Onset of effect of aclidinium, a novel, long-acting muscarinic antagonist, in patients with COPD
Jørgen Vestbo, Claus Vogelmeier, Jacques Creemers, et al.
Fish & Shellfish Immunology
|
September 24, 2013
Structural and functional characterization of the Senegalese sole (Solea senegalensis) Mx promoter
Daniel Alvarez-Torres, Julia Bejar, Bertrand Collet, et al.
Fish & Shellfish Immunology
|
November 20, 2025
Functional assessment of European sea bass RTP3 proteins and their effect on RGNNV replication
Patricia Moreno, Daniel Alvarez-Torres, Esther Garcia-Rosado, et al.
International Forum of Allergy & Rhinology
|
May 26, 2017
Household pet exposure, allergic sensitization, and rhinitis in the U.S. population
Josef Shargorodsky, Esther Garcia-Esquinas, Rachel Umanskiy, et al.
Respiratory Medicine
|
November 12, 2013
Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD
Henry Chrystyn, Mark Small, Gary Milligan, et al.
Elife
|
January 13, 2021
ARL3 activation requires the co-GEF BART and effector-mediated turnover
Yasmin ElMaghloob, Begoña Sot, Michael J McIlwraith, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
December 19, 2013
Impact of night-time symptoms in COPD: a real-world study in five European countries
David Price, Mark Small, Gary Milligan, et al.
Fish & Shellfish Immunology
|
August 25, 2022
Cytokine-like activity of European sea bass ISG15 protein on RGNNV-infected E-11 cells
Patricia Moreno, Rocio Leiva-Rebollo, Esther Garcia-Rosado, et al.
Nature and Science of Sleep
|
March 25, 2021
Social Network and Risk of Poor Sleep Outcomes in Older Adults: Results from a Spanish Prospective Cohort Study
Rocio Leon-Gonzalez, Fernando Rodriguez-Artalejo, Rosario Ortola, et al.
Journal of Clinical Gastroenterology
|
May 7, 2009
Infliximab reintroduction is not associated to a higher rate of immune-related adverse effects in patients with inflammatory bowel disease initially treated with a three-infusion induction regimen
Eugeni Domènech, Yamile Zabana, Míriam Mañosa, et al.
Page
of 28
Search research articles
Search
Showing results (41-50 of 280) with videos related to
Sort By:
Page
of 28
COPD
|
September 22, 2010
Onset of effect of aclidinium, a novel, long-acting muscarinic antagonist, in patients with COPD
Jørgen Vestbo, Claus Vogelmeier, Jacques Creemers, et al.
Fish & Shellfish Immunology
|
September 24, 2013
Structural and functional characterization of the Senegalese sole (Solea senegalensis) Mx promoter
Daniel Alvarez-Torres, Julia Bejar, Bertrand Collet, et al.
Fish & Shellfish Immunology
|
November 20, 2025
Functional assessment of European sea bass RTP3 proteins and their effect on RGNNV replication
Patricia Moreno, Daniel Alvarez-Torres, Esther Garcia-Rosado, et al.
International Forum of Allergy & Rhinology
|
May 26, 2017
Household pet exposure, allergic sensitization, and rhinitis in the U.S. population
Josef Shargorodsky, Esther Garcia-Esquinas, Rachel Umanskiy, et al.
Respiratory Medicine
|
November 12, 2013
Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD
Henry Chrystyn, Mark Small, Gary Milligan, et al.
Elife
|
January 13, 2021
ARL3 activation requires the co-GEF BART and effector-mediated turnover
Yasmin ElMaghloob, Begoña Sot, Michael J McIlwraith, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
December 19, 2013
Impact of night-time symptoms in COPD: a real-world study in five European countries
David Price, Mark Small, Gary Milligan, et al.
Fish & Shellfish Immunology
|
August 25, 2022
Cytokine-like activity of European sea bass ISG15 protein on RGNNV-infected E-11 cells
Patricia Moreno, Rocio Leiva-Rebollo, Esther Garcia-Rosado, et al.
Nature and Science of Sleep
|
March 25, 2021
Social Network and Risk of Poor Sleep Outcomes in Older Adults: Results from a Spanish Prospective Cohort Study
Rocio Leon-Gonzalez, Fernando Rodriguez-Artalejo, Rosario Ortola, et al.
Journal of Clinical Gastroenterology
|
May 7, 2009
Infliximab reintroduction is not associated to a higher rate of immune-related adverse effects in patients with inflammatory bowel disease initially treated with a three-infusion induction regimen
Eugeni Domènech, Yamile Zabana, Míriam Mañosa, et al.
Page
of 28